Clinical Trial 35940

Garden Grove, CA 92845


Study Summary:

The study will evaluate the efficacy and safety of ITI-007 adjunctive in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode. The trial may take up to 6 weeks.


Qualified Participants Must:

• Be between 18 and 65 years of age (Adult)
• Be experiencing a current major depressive episode


Qualified Participants May Receive:

Study-related medical care and investigational drug at no cost and may be compensated for time and travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.